Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-24-015434
Filing Date
2024-01-25
Accepted
2024-01-25 16:26:29
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d690687dsc13da.htm SC 13D/A 68242
  Complete submission text file 0001193125-24-015434.txt   69813
Mailing Address TUBORG HAVNEVEJ 19 HELLERUP G7 2900
Business Address TUBORG HAVNEVEJ 19 HELLERUP G7 2900 45 8824 8824
Novo Holdings A/S (Filed by) CIK: 0001388325 (see all company filings)

EIN.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 1715 38TH ST BOULDER CO 80301
Business Address 1715 38TH ST BOULDER CO 80301 720-262-7002
Edgewise Therapeutics, Inc. (Subject) CIK: 0001710072 (see all company filings)

EIN.: 821725586 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92424 | Film No.: 24562529
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)